Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System

Withdrawn before enrolling

Conditions studied: Pulmonary Embolism, Venous Thromboembolism, Deep Vein Thrombosis

In brief

The Crux Vena Cava Filter (VCF) Registry is a clinical study, sponsored by Volcano Corporation, to evaluate the short and long term performance and clinical outcomes of the Crux Vena Cava Filter System.

Key facts

Study ID

NCT02420626

Run by

Volcano Corporation

People needed

0

Starts

2016-01-01

Expected to finish

2019-05-01

Last updated by the study team

2016-04-22

Who can join

Age: 19 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The patient is >18 years of age.
• Patient or their legally authorized representative understands the research nature of the study and is willing and capable of providing informed consent.
• Scheduled for and receives a Crux VCF implant or;
• Have previously had a Crux VCF implanted within the previous 6 months.

You may not qualify if…

• Patient is scheduled for filter implant, but did not have a Crux VCF filter implanted due to anatomical exclusions or technical failures.
• Patients unwilling or unable to comply with the protocol and provide informed consent.
• Female patient of childbearing potential who is pregnant (she must have negative pregnancy test within the 48 hours prior to implantation and any retrieval procedure)
• Patient is participating in another device or drug clinical trial that interferes with this protocol follow up schedule.

Where it is running

• Northside Vascular Surgery — Atlanta, Georgia, United States
• Rex Healthcare — Raleigh, North Carolina, United States
• Turkey Creek Medical Center — Knoxville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.